Background and Objectives IgG4 autoantibodies to neurofascin-155 (Nfasc155) are associated with a subgroup of patients with chronic inflammatory demyelinating polyneuropathy (CIDP), currently named autoimmune nodopathy.…
Introduction Glial fibrillar acidic protein (GFAP), a marker of astroglia activation, has been proposed as a biomarker of Alzheimer’s disease (AD).1 GFAP expression correlates with…
When faced with challenging clinical situations, we often ask our colleagues: Can I pick your brain? As clinicians, we aim to provide evidence-based care, often…
Background and Objectives Transient global amnesia (TGA) is an acute amnestic disorder with unclear pathophysiology. Although considered a benign phenomenon, the possibility of a recurrence…
Background and Objectives Epilepsy is an important comorbidity that affects outcomes for people with multiple sclerosis (MS). However, it is unclear whether seizure severity among…
Background and Objectives Disease activity in multiple sclerosis (MS) is highly variable, and there are limited prospective studies on predictors of disease outcomes. The goal…
Background and Objectives There have been numerous reports of neurologic manifestations identified in hospitalized patients infected with SARS-CoV-2, the virus that causes COVID-19. Here, we…
Objectives Area postrema syndrome (APS) is one of the core clinical features of neuromyelitis optic spectrum disorder (NMOSD). APS is mostly associated with neuromyelitis optica…
Purpose of Review To perform a systematic review and determine the prevalence of rhinorrhea in Parkinson disease (PD). Recent Findings Of 451 patients with PD…
Background and Objectives Specialty palliative care (PC) may benefit patients with dementia by aligning treatment with goals and relieving symptoms. We aimed to compare demographics…
English
العربية
简体中文
Nederlands
Français
Deutsch
Italiano
Português
Русский
Español